Fast Company has an interview with 23andMe co-founders, Linda Avey and Anne Wojcicki. Mostly they talk about using genetic testing information to form social networks and to give people the opportunity to connect on different, possibly deeper, levels as per health-related concerns. "Part of the thing that really motivated me in getting into this was adverse events," Avey says. "I would love to have cancer patients be able to walk in five years from now and get their tumor genotyped and know they should be taking this kind of drug instead of that one."
Most Importantly, Anne Has the "Likes Brussels Sprouts" Gene
Apr 08, 2008